Proper Dietary Management, Follow-up, and Lactase Enzyme Supplementation for Lactose Intolerance
Condition(s) studied
Investigational drug(s) / intervention(s)
Completion of online survey: The online survey aims to reach a representative sample of the Italian population to identify their knowledge regarding LI
Study summary
Lactose intolerance (LI) is considered the clinical syndrome caused by lactose malabsorption (LM).
It is possible to identify four causes of lactase deficiency defining four different types of LM: primary (genetic), secondary (acquired), congenital (alactasia), and developmental (in premature infants, so reversible).
The aim of this protocol is to investigate through an anonymous online survey the knowledge of the Italian population on clinical, pathophysiological, diagnostic and therapeutic issues of lactose intolerance. Data collected will be divulgated through a publication for both people with IL and nutritionists, enriched with tables and flow charts, to improve the knowledge on lactose intolerance and to support people suffering from this condition. The results of this survey will guide subjects suspected of suffering from lactose intolerance towards a correct diagnosis and a better management.
Eligibility
Primary outcome measure(s)
- Evaluation of knowledge of the Italian population on lactose intolerance — 3 months
The aim of this protocol is to investigate through an anonymous online survey the knowledge of the Italian population on clinical, pathophysiological, diagnostic and therapeutic issues of lactose intolerance
Trial sites (1)
| Facility | City | Region | Status |
|---|---|---|---|
| European Institute of Oncology | Milan | Italy | Recruiting |
More European Institute of Oncology trials in Italy
This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.
View NCT06773650 on ClinicalTrials.gov ↗ ← All trials in Italy